Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
As filed · Dr. Reddy's Laboratories Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
What happened
FactDr. Reddy's Laboratories has received a show cause notice from the Office of the Assistant Commissioner of Income Tax regarding the reassessment of income for the Assessment Year 2020-21, related to the merger of Dr. Reddy’s Holding Limited into Dr. Reddy’s Laboratories Limited. The notice proposes a demand of Rs. 2395,81,79,470, but the company assesses that there is no material impact on its financials, operations, or other activities at this stage.
Why it matters
CapitSignal interpretationLitigation creates a contingent liability that is not in reported profit until it crystallises.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Guidance
WithdrawnSo, altogether, right now, we are targeting 27.
It should be in the range of tens of millions of dollars, that specific launch.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Amount claimed against the company
- Whether a provision has been made
- Next hearing or order date
- I believe, 100 plus of million dollars coming to us as a growth in the next 2 to 3 years from that. (management committed by H1 FY28)
- So, altogether, right now, we are targeting 27. (management committed by FY27)
Evidence
- Dr. Reddy's Laboratories Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q3 FY26
How CapitSignal classified this
- Reasoning:
- LITIGATION base 56; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%